Additional studies are needed to further delineate if the association between CHIP and CVD exists in other cancer populations (eg, solid tumors, nonleukemic hematologic cancers) and to interrogate the specific gene-environment interactions that modulate long-term CVD risk. The gene discussed is STUB1; the disease is hematopoietic and lymphoid cell neoplasm.